Orexo - Termination of coverage
Edison Investment Research is terminating coverage on BONESUPPORT, Orexo, Transcontainer and UmweltBank. Please note you should no longer rely on...
93 Views
Orexo - Updates from the capital markets day
On 17 March 2020 Orexo held a capital markets day at which it provided an update on its programs and estimates of the impact of COVID-19 on its...
588 Views
Orexo - Vorvida submitted to the FDA
Orexo announced on 6 March 2020 that it has submitted an application to the FDA for its vorvida digital therapy for the treatment of heavy...
692 Views
Orexo - Zubsolv stabilizing enables R&D push
Orexo continues to weather the shift in its payer base away from exclusivity to the open market well. It has managed to maintain 4% sequential...
655 Views
Orexo - Record quarter reflecting shifting US market
Orexo reported a record performance for Q319 with revenue of SEK231.2m (+6.7% year-on-year). The top line was lifted by a combination of factors...
906 Views
No more insights